Articles by Jill Wechsler - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jill Wechsler

Jill Wechsler


Jill Wechsler is BioPharm International's Washington editor.

Articles
Biopharma Manufacturers Respond to Ebola Crisis
October 1, 2014

Demand for new therapies and vaccines spotlights production challenges.

Data Integrity Key to GMP Compliance
September 1, 2014

FDA demands accurate manufacturing and test information to ensure product quality.

Suppliers Seek to Boost Single-Use Technology
August 21, 2014

Attendees at the Bio-Process Systems Alliance annual summit discuss the benefits of single-use technology in biopharmaceutical manufacturing.

Changes and Challenges for Generic Drugs
August 1, 2014

FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.

Supplier Audit Program Marks Progress
July 1, 2014

Supplier Audit Program Marks Progress

Industry Seeks Clearer Standards for Track and Trace
July 1, 2014

Stakeholders face challenges and benefits from a more secure pharmaceutical supply chain.

Global Expansion Shapes Drug Oversight
June 1, 2014

Regulators and industry organizations explain policies and standards to manufacturers and authorities in all regions.

Demand for New Vaccines Spurs Innovation
May 1, 2014

New formulations and expanded vaccine production are encouraged.

FDA and Manufacturers Seek a More Secure Drug Supply Chain
April 1, 2014

New identifiers and tracking requirements aim to block illegitimate products.

ADVERTISEMENT

ADVERTISEMENT

Click here